Lowest Free Cash Flow Per Share in the Pharmaceuticals Industry Detected in Shares of Pozen (POZN, AKRX, IPXL, CPIX, SCLN)
Below are the three companies in the Pharmaceuticals industry with the lowest (positive) free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.
Pozen ranks lowest with a FCF per share of $0.01. Akorn is next with a FCF per share of $0.01. Impax Laboratories ranks third lowest with a FCF per share of $0.04.
Cumberland Pharmaceuticals follows with a FCF per share of $0.37, and Sciclone Pharmaceuticals rounds out the bottom five with a FCF per share of $0.51.
SmarTrend recommended that its subscribers protect gains by selling shares of Sciclone Pharmaceuticals on July 19th, 2016 by issuing a Downtrend alert when the shares were trading at $10.89. Since that call, shares of Sciclone Pharmaceuticals have fallen 9.6%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
Keywords: lowest free cash flow per share pozen akorn impax laboratories cumberland pharmaceuticals sciclone pharmaceuticals